ArticleHemaSphere2021

Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network.

Barbara Mantoan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.